1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. FRACTYL HEALTH INC.
Fractyl Health Inc.
XNAS: GUTS
4.23-0.29(-6.42%)
300.5K
XNAS Volume

XNAS 08 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Fractyl Health Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Fractyl Health Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Fractyl Health Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Fractyl Health Inc Jun-2026 Quarterly Net Profit is $-26 Million which is growth of 8.4% YoY.

Fractyl Health Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
000000.1
Cost Of Rev.
--00000.1
Gross Profit
-000000
⌄
19.120.823.322.726.124.825.223.82321.61313.911.9
Operating Profit
-19.1-20.8-23.3-22.7-26.1-24.8-25.2-23.8-23-21.5-13-13.9-11.9
0.40.60.70.20.20.50.711.41.10.50.20.2
Profit Before Tax
-25.59.2-43.7-45.6-27.9-23.7-25-23.2-17.2-3.3-19.2-15.8-30.2
Tax
-------------
⌄
-25.59.2-43.7-45.6-27.9-23.7-25-23.2-17.2-5.1-23.5-20.1-34.5
Diluted NI Avail to Com Stockholders Ann.
-25.59.2-43.7-45.6-27.9-23.7-25-23.2-17.2-5.1-23.5-20.1-34.5
Basic EPS
-1.90.7-0.8-8.5-6.8-5.9-6.2-5.8-4.3-2-5.9-2.9-3.5
Diluted EPS After ExtraOrdinary
-------------
Number Of Shares End
13.213.212.85.44.14.14442.546.99.8
Net Income Continuing Discontinued Operations
-25.59.2-43.7-45.6-27.9-23.7-25-23.2-17.2-3.3-19.2-15.8-30.2
Normalized Income
-20.1-8.8-23.6-24.4-27.5-24.6-25.4-25.5-21.9-13.8-13.6-14.7-30.1
Interest Income
0.40.60.70.20.20.50.711.41.10.50.20.2
Interest
-------------
Net Interest Income
0.40.60.70.20.20.50.711.41.10.50.20.2
EBIT
-19.1-20.8-23.3-22.7-26.1-24.8-25.2-23.8-23-21.5-13-13.9-11.9
EBITDA
-18.8-20.5-23-22.4-25.8-24.5-25-23.6-22.8-21.5-12.9-13.8-11.8
Reconciled Cost Of Rev.
--00000.1
Reconciled Depr.
0.30.30.30.30.30.30.20.20.20.100.10.1
Profit From Continuing Operations
-25.59.2-43.7-45.6-27.9-23.7-25-23.2-17.2-3.3-19.2-15.8-30.2
Normalized EBITDA
-13.3-50.6-2.8-1.2-25.5-25.3-25.5-25.9-27.5-31.9-7.3-12.8-11.7
*All financials are in USD Million and price data in USD

Fractyl Health Inc competitor comparison and performance snapshot within industry

Fractyl Health Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEGATIVE

    Annual Revenue Fractyl Health Inc Annual Revenue is $0 Million which is growth of -100.0% YoY.

  • NEGATIVE

    Annual Net Profit Fractyl Health Inc Annual Net Profit is $-141 Million which is growth of -105.2% YoY.

Fractyl Health Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
-
-
 0.10.1
Cost Of Rev. Ann.
-
-
 0.10.1----
Gross Profit Ann.
-
-
 00----
Operating Exp. Ann.
25.1%
27.3%
85.996.893.650.949.436.92929.9
Operating Profit Ann.
-
-
-85.9-96.8-93.5-50.8-49.4-36.9-29-29.9
23.3%
-
1.81.54.21.30.8-1.4-1.5-0.6
Other Exp. Ann.
-
-
 -45.720.7-27.52.1-0.4-0-0
PBT Ann.
-
-
-105.7-141-68.7-77.1-46.5-38.7-30.5-30.6
Tax Ann.
-
-
 -------
⌄
-
-
-105.7-141-70.4-94.3-63.6-53.2-40.9-38.5
Diluted NI Avail to Com Stockholders Ann.
-
-
-105.7-141-70.4-94.3-63.6-53.2-40.9-38.5
EPS Ann.
-
-
 -22.3-19.4-23.8-16-6.1-5.4-9.7
Diluted EPS Ann.
-
-
 -22.3-19.4-23.8-16-6.1-5.4-9.7
Number Of Shares End
47.4%
-
 12.84446.8--
Total Exp. Ann.
25.1%
27.3%
 96.893.65149.436.92929.9
Net Income Continuing Discontinued Operations Ann.
-
-
-105.7-141-68.7-77.1-46.5-38.7-30.5-30.6
Normalized Income Ann.
-
-
-76.8-100.1-86.6-70.3-46.3-38.4-30.5-30.6
Interest Income Ann.
-
-
1.81.54.21.3----
Interest Ann.
-
-
 ----1.41.50.6
EBITDA Ann.
-
-
-84.8-95.7-92.9-50.6-48.9-36.6-28.2-29.1
Reconciled Cost Of Rev. Ann.
-
-
 0.10.1----
Reconciled Depr. Ann.
30.1%
6.6%
1.11.10.70.30.50.70.80.9
Profit From Continuing Operations Ann.
-
-
-105.7-141-68.7-77.1-46.5-38.7-30.5-30.6
Normalized EBITDA Ann.
-
-
-68-54.8-110.8-43.8-48.8-36.3-28.2-29
*All financials are in USD Million and price data in USD
Operating Exp. Ann.
1Y CHG
3.4%
2Y CAGR
37.9%
3Y CAGR
25.1%
5Y CAGR
27.3%

Fractyl Health Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Fractyl Health Inc Dec-2025 Total Shareholders Fund is $9 Million which is growth of -66.7% YoY.

  • POSITIVE

    Total Assets Fractyl Health Inc Dec-2025 Total Assets is $121 Million which is growth of 12.3% YoY.

Fractyl Health Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
25.8%
28.4%
121.4108.176.261102.634.88.9
⌄
-29%
-11.6%
111.979.7401.3313.3311.9207.5152.9
⌄
-
-
9.528.4-325.1-252.3-209.3-172.7-144
Total Capitalization Ann.
-
-
4058.6-269.9-234.6-209.3-164.6-129.1
Tangible Assets Ann.
-
-
9.528.4-325.1-252.3-209.3-172.7-144
Working Capital Ann.
16.1%
28.2%
69.35224.544.372.7203.4
Invested Capital Ann.
-
-
4058.6-269.9-234.6-193.6-157.4-129.1
Tangible Book Value Ann.
-
-
9.528.4-325.1-252.3-209.3-172.7-144
Borrowings Ann.
46.8%
32.2%
61.762.586.419.51715.314.9
Net Debt Ann.
-
-
--21.9---9.7
Share Issued Ann.
47.7%
26.4%
153.448.847.947.647.647.647.6
Number Of Shares End
47.4%
-
12.84446.8--
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
12.3%
2Y CAGR
26.2%
3Y CAGR
25.8%
5Y CAGR
28.4%
Total Current Liabilities Ann.
1Y CHG
-7.6%
2Y CAGR
27.8%
3Y CAGR
35.8%
5Y CAGR
10.9%
Total ShareHolders Funds Ann.
1Y CHG
-66.5%

Fractyl Health Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Fractyl Health Inc Book Value Per Share is $-0 which is growth of -102.0% YoY.

  • NEUTRAL

    ROE Fractyl Health Inc ROE is 0% which is growth of 0% YoY.

Fractyl Health Inc., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
RoA Ann. %
-
-
--76.44%-137.45%-77.84%-77.52%-187.22%-430.58%
ROE Ann. %
-
-
-------
ROIC %
-
-
--25.2-----
OPM Ann. %
-
-
--100,570.97%-42,363.33%----
Inventory Turnover Ratio Ann.
-
-
-0.71.1----
Asset Turnover Ann. %
-
-
-----
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-3.436.742.71.5
Current Ratio Ann.
-
-
-3.63.27.14.12.82
Interest Coverage Ratio Ann.
-
-
-----25.9-19.3-47.2
LT Debt To Equity Ann.
-
-
-2-----
*All financials are in USD Million and price data in USD

Fractyl Health Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Fractyl Health Inc Cash From Operating Activity is $-90 Million which is growth of -37.9% YoY.

  • NEGATIVE

    Net Cash Flow Fractyl Health Inc Net Cash Flow is $14 Million which is growth of -58.5% YoY.

Fractyl Health Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19
-
-
-90.3-65.5-42.8-46.2-33.5-31.1-27.7
-
-
-0.6-1.8-0.4-0.1-0.1-0.1
187.9%
14.1%
105101.227.44.499.954.415.2
Cash Plus Cash Eqv. End Of Year Ann.
17.1%
24.1%
85.871.737.853.595.529.15.8
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-9.6%
14.133.9-15.7-4266.423.3-12.7
Cash Plus Cash Eqv. Begin Of Year Ann.
-9.1%
65.4%
71.737.853.595.529.15.818.5
Income Tax Paid Supplemental Data Ann.
-
-
-------
Interest Paid Supplemental Data Ann.
-
33.9%
4.33.10.80110.5
Capex Ann.
-
-
-0.6-1.8-0.4-0.1-0.1-0.1
Issuance Of Capital Stock Ann.
-
9.4%
85.4103.7-99.954.4
Issuance Of Debt Ann.
-
-
-28.420.1-15
Repayment Of Debt Ann.
-
-
-0.5-0.2-0.1-16.1-0-0-0
Repurchase Of Capital Stock Ann.
-
-
-------
Free Cash Flow Ann.
-
-
-90.9-67.3-43.2-46.3-33.5-31.1-27.8
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
3.8%
2Y CAGR
95.8%
3Y CAGR
187.9%
5Y CAGR
14.1%